
Episode 20. Management of Myeloma in LMICs
Blood Cancer Talks
The Importance of Infrastructure for Clinical Trials in India
There are very few in investigator initiated trials. The reason is because of very stringent rules that have been laid down by the regulatory authorities. A hematologist in India, I see AML. I also see thalassemia, emophilia, ITP, autoimmune,. He doesn't think we have dedicated time to do focus research and clinical trial. On top of that, we do not have infrastructure basically to conduct phase one or phase two trials.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.